Avalo Therapeutics (AVTX) closed at $7.76 on November 13, 2026, up 0.8% from the previous close, on volume of 910,720 shares (30-day average 2,415,958).
Data as of November 13, 2026.
13-Nov-2026
| # | Date | Strategy | Legs | Contracts | Position |
|---|---|---|---|---|---|
| 1 | Oct 23, 2026 | Straddle or Synthetic | 18-Dec-267.5 C : 7.5 P | 4,730 |
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 12, 2026. See the 10 largest for 30, 60 and 90 days
Avalo Therapeutics Reports Third Quarter 2026 Financial Results and Recent Business Updates
Globe Newswire (Thu, 5-Nov 7:00 AM ET)
Avalo Therapeutics to Participate in Upcoming Investor Conferences
Globe Newswire (Mon, 2-Nov 4:00 PM ET)
Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire (Tue, 29-Sep 4:01 PM ET)
Globe Newswire (Wed, 23-Sep 7:00 AM ET)
Market Chameleon (Wed, 6-May 5:54 AM ET)
Market Chameleon (Wed, 6-May 3:05 AM ET)
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.
Avalo Therapeutics trades on the NASDAQ stock market under the symbol AVTX.
As of November 13, 2026, AVTX stock price climbed to $7.76 with 910,720 million shares trading.
AVTX has a beta of 1.62, meaning it tends to be more sensitive to market movements. AVTX has a correlation of 0.04 to the broad based SPY ETF.
AVTX has a market cap of $448.71 million. This is considered a Small Cap stock.
In the last 3 years, AVTX traded as high as $34.46 and as low as $3.39.
The top ETF exchange traded funds that AVTX belongs to (by Net Assets): VTI, XBI, IWM, VXF, VTWO.
AVTX has underperformed the market in the last year with a return of -49.7%, while the SPY ETF gained +11.5%. In the last 3 month period, AVTX fell short of the market, returning -60.3%, while SPY returned -2.1%. However, in the most recent 2 weeks AVTX has outperformed the stock market by returning +4.3%, while SPY returned -1.9%.
AVTX support price is $7.23 and resistance is $8.17 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AVTX shares will trade within this expected range on the day.
